Cargando…

Surgery of Primary Melanomas

Surgery remains the mainstay of melanoma therapy, regardless of the tumor site. Only the early diagnosis combined with proper surgical therapy currently gives patients affected by this malignancy the chance for a full cure. The main goal of surgical therapy is to provide the local control of the dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutkowski, Piotr, Zdzienicki, Marcin, Nowecki, Zbigniew I., van Akkooi, Alexander C. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835107/
https://www.ncbi.nlm.nih.gov/pubmed/24281096
http://dx.doi.org/10.3390/cancers2020824
_version_ 1782292101832114176
author Rutkowski, Piotr
Zdzienicki, Marcin
Nowecki, Zbigniew I.
van Akkooi, Alexander C. J.
author_facet Rutkowski, Piotr
Zdzienicki, Marcin
Nowecki, Zbigniew I.
van Akkooi, Alexander C. J.
author_sort Rutkowski, Piotr
collection PubMed
description Surgery remains the mainstay of melanoma therapy, regardless of the tumor site. Only the early diagnosis combined with proper surgical therapy currently gives patients affected by this malignancy the chance for a full cure. The main goal of surgical therapy is to provide the local control of the disease and to secure long-term survival of the patient without reasonable functional and esthetic impairment. The recommended method of biopsy—excisional biopsy, as an initial diagnostic and, to some extent, therapeutic procedure—is performed under local anesthesia as an elliptical incision with visual clear margins of 1–3 mm and with some mm of subcutaneous tissue. The extent of radical excision of the primary tumor (or scar after excisional biopsy) is based on the histopathologic characteristics of the primary tumor and usually consists of 1–2 cm margins with primary closure. The philosophy behind conducted randomized clinical trials has been to find the most conservative surgical approach that is able to guarantee the same results as more demolitive treatment. This has been the background of the trials designed to define the correct margins of excision around a primary cutaneous melanoma. Much less definition can be dedicated to the surgical management of patients with non-cutaneous melanomas.
format Online
Article
Text
id pubmed-3835107
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-38351072013-11-21 Surgery of Primary Melanomas Rutkowski, Piotr Zdzienicki, Marcin Nowecki, Zbigniew I. van Akkooi, Alexander C. J. Cancers (Basel) Review Surgery remains the mainstay of melanoma therapy, regardless of the tumor site. Only the early diagnosis combined with proper surgical therapy currently gives patients affected by this malignancy the chance for a full cure. The main goal of surgical therapy is to provide the local control of the disease and to secure long-term survival of the patient without reasonable functional and esthetic impairment. The recommended method of biopsy—excisional biopsy, as an initial diagnostic and, to some extent, therapeutic procedure—is performed under local anesthesia as an elliptical incision with visual clear margins of 1–3 mm and with some mm of subcutaneous tissue. The extent of radical excision of the primary tumor (or scar after excisional biopsy) is based on the histopathologic characteristics of the primary tumor and usually consists of 1–2 cm margins with primary closure. The philosophy behind conducted randomized clinical trials has been to find the most conservative surgical approach that is able to guarantee the same results as more demolitive treatment. This has been the background of the trials designed to define the correct margins of excision around a primary cutaneous melanoma. Much less definition can be dedicated to the surgical management of patients with non-cutaneous melanomas. Molecular Diversity Preservation International (MDPI) 2010-05-11 /pmc/articles/PMC3835107/ /pubmed/24281096 http://dx.doi.org/10.3390/cancers2020824 Text en © 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Rutkowski, Piotr
Zdzienicki, Marcin
Nowecki, Zbigniew I.
van Akkooi, Alexander C. J.
Surgery of Primary Melanomas
title Surgery of Primary Melanomas
title_full Surgery of Primary Melanomas
title_fullStr Surgery of Primary Melanomas
title_full_unstemmed Surgery of Primary Melanomas
title_short Surgery of Primary Melanomas
title_sort surgery of primary melanomas
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835107/
https://www.ncbi.nlm.nih.gov/pubmed/24281096
http://dx.doi.org/10.3390/cancers2020824
work_keys_str_mv AT rutkowskipiotr surgeryofprimarymelanomas
AT zdzienickimarcin surgeryofprimarymelanomas
AT noweckizbigniewi surgeryofprimarymelanomas
AT vanakkooialexandercj surgeryofprimarymelanomas